Literature DB >> 8424514

Influence of age on awakening concentrations of sevoflurane and isoflurane.

T Katoh1, Y Suguro, T Ikeda, T Kazama, K Ikeda.   

Abstract

We determined whether age, duration of anesthesia, gender, or type of surgery significantly influenced end-tidal concentrations on awakening from anesthesia with sevoflurane and isoflurane in 39 healthy ASA physical status I patients. Postoperatively, the end-tidal anesthetic concentration was maintained at a constant level at least for 15 min. If patients failed to open their eyes on request, the end-tidal concentration was decreased and again maintained at a constant level for 15 min. The anesthetic concentration midway between the value permitting the response and that just preventing the response was recorded. The end-tidal concentrations on awakening from anesthesia were 0.62 +/- 0.02% (mean +/- SE) for sevoflurane and 0.41 +/- 0.02% for isoflurane. Awakening concentration of sevoflurane and isoflurane correlated significantly with age (P < 0.001), but not with duration of anesthesia, gender, or type of surgery. The authors conclude that awakening concentration decreases at the similar rate of decrease in minimum alveolar concentration (MAC) with increasing age; and therefore, the ratios to MAC are fairly constant, being 0.34 for both sevoflurane and isoflurane.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8424514

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  21 in total

Review 1.  [Pharmacokinetic-pharmacodynamic models for inhaled anaesthetics].

Authors:  S Kreuer; J Bruhn; W Wilhelm; T Bouillon
Journal:  Anaesthesist       Date:  2007-06       Impact factor: 1.041

2.  Ageing delays emergence from general anaesthesia in rats by increasing anaesthetic sensitivity in the brain.

Authors:  J J Chemali; J D Kenny; O Olutola; N E Taylor; E Y Kimchi; P L Purdon; E N Brown; K Solt
Journal:  Br J Anaesth       Date:  2015-07       Impact factor: 9.166

3.  Effect of flumazenil on sevoflurane requirements for minimum alveolar anesthetic concentration-awake and recovery status.

Authors:  Peng Liang; Cheng Zhou; Kai-Yu Li; Li-Juan Guo; Bin Liu; Jin Liu
Journal:  Int J Clin Exp Med       Date:  2014-03-15

4.  The Role of Anesthetic Management in Surgical Site Infections After Pediatric Intestinal Surgery.

Authors:  Miho Shibamura-Fujiogi; Jennifer Ormsby; Mark Breibart; Jill Zalieckas; Thomas J Sandora; Gregory P Priebe; Koichi Yuki
Journal:  J Surg Res       Date:  2020-11-19       Impact factor: 2.192

5.  Effects of four volatile anesthesics on postanesthetic ventilation: a comparison of halothane, enflurane, isoflurane, and sevoflurane.

Authors:  Yoshimi Inagaki; Chikara Tashiro; Yoshihiro Miwa; Ikuto Yoshiya
Journal:  J Anesth       Date:  1996-06       Impact factor: 2.078

6.  Sevoflurane 0.25 MAC preferentially affects higher order association areas: a functional magnetic resonance imaging study in volunteers.

Authors:  Ramachandran Ramani; Maolin Qiu; Robert Todd Constable
Journal:  Anesth Analg       Date:  2007-09       Impact factor: 5.108

7.  Morphine does not affect the awakening concentration of sevoflurane.

Authors:  T Katoh; Y Suguro; T Kimura; K Ikeda
Journal:  Can J Anaesth       Date:  1993-09       Impact factor: 5.063

8.  Bispectral index monitor: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2004-06-01

9.  Comparison of haemodynamic changes induced by sevoflurane and halothane in paediatric patients.

Authors:  S Kawana; J Wachi; M Nakayama; A Namiki
Journal:  Can J Anaesth       Date:  1995-07       Impact factor: 5.063

10.  Response surface model predictions of emergence and response to pain in the recovery room: An evaluation of patients emerging from an isoflurane and fentanyl anesthetic.

Authors:  Noah D Syroid; Ken B Johnson; Nathan L Pace; Dwayne R Westenskow; Diane Tyler; Frederike Brühschwein; Robert W Albert; Shelly Roalstad; Samuel Costy-Bennett; Talmage D Egan
Journal:  Anesth Analg       Date:  2010-08       Impact factor: 5.108

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.